Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : °øÁö»çÇ×
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [±â»ç]¾à»ç Á÷´É ¹Ì·¡ Á¸¸³ÀÇ ÇØ¹ýÀº 'ȯÀÚ¿ÍÀÇ ¼ÒÅë'
³»   ¿ë

¾à»ç Á÷´É ¹Ì·¡ Á¸¸³ÀÇ ÇØ¹ýÀº 'ȯÀÚ¿ÍÀÇ ¼ÒÅë'

[â°£ 49Áֳ⠼³¹®¨è] ºÐȸÀå 41.6% ÀÀ´ä¡¦"AI½Ã´ë »õ Àü¹®¼º ¹ßÈÖ" Àü¸Á

[ⰣƯÁý¼³¹®¨è] ¾à»ç, ±¹¹Î°ú ÅëÇØ¾ß ¹Ì·¡·Î ³ª¾Æ°£´Ù

¾à»ç°ø·ÐÀº 2017³â ⰣƯÁýÀ¸·Î ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò¿Í ÇÔ²² Àü±¹ ºÐȸÀåµéÀ» ´ë»óÀ¸·Î `¼ÒÅë'°ú `¾à»çÀÇ ¹Ì·¡'¸¦ ³»¿ëÀ¸·Î ÇÏ´Â ¼³¹®Á¶»ç¸¦ ½Ç½ÃÇß´Ù. ¼³¹®Á¶»ç´Â 6¿ù 9ÀϺÎÅÍ 7¿ù3ÀϱîÁö ¿Â¶óÀΰú ÀüÈ­, ÆÑ½º¸¦ ÀÌ¿ëÇØ ÁøÇàµÆ´Ù. Á¶»ç¿¡´Â Àüü 224¸í Áß 161¸íÀÌ ´äº¯ÇØ 71.9%ÀÇ ÀÀ´ä·üÀ» ±â·ÏÇß´Ù. ÀÀ´äÀÚ¸¦ ¼ºº°·Î º¸¸é ³²¼º 128(79%), ¿©¼º 33¸í(20.5%)À̾úÀ¸¸ç ¿¬·Éº°·Î º¸¸é 51~60¼¼ ±¸°£ÀÌ 54.7%·Î °¡Àå ¸¹¾Ò°í ¼­¿ïÁö¿ª ºÐȸÀåµéÀÌ 14.3%·Î °¡Àå ÀÀ´ä·üÀÌ ³ô¾Ò´Ù. [ÆíÁýÀÚÁÖ]

¾ËÆÄ°í°¡ Àΰ£ »îÀÇ Áú Á¦°í¸¦ À§ÇÑ µµ±¸·Î Ȱ¿ëµÉ °ÍÀÎÁö, Àΰ£À» Áö¹èÇÏ´Â ½Å°ú °°Àº Á¸Àç°¡ µÉ °ÍÀÎÁö ÇöÀ縦 »ì¾Æ°¡´Â ¿ì¸®¿¡°Õ ¼¶¶àÇÑ ºÒ¾È°¨À¸·Î ´Ù°¡¿Â´Ù. ¾à»ç¶õ Á÷¾÷µµ ¿¹¿Ü´Â ¾Æ´Ï´Ù. ÀÌ¹Ì µîÀåÇÑ Á¶Á¦·Îº¿ÀÌ ¾à»ç¶õ Á÷´ÉÀ» À§ÇùÇÏÁö ¾ÊÀ»±î ÇÏ´Â ºÒ¾È°¨À» °®°í ÀÖ´Â °ÍÀÌ´Ù.

ÀþÀºÃþ-¿©¼º-´ëµµ½Ã ºÐȸÀåµé, Á¶Á¦·Îº¿ µî AI¿¡ ´õ '¹Î°¨'

Á¶Á¦·Îº¿ µî AI½Ã´ëÀÇ µµ·¡°¡ ¾à»ç»çȸ¿¡ ¾î´À Á¤µµ ¿µÇâ·ÂÀÌ ÀÖÀ» °ÍÀΰ¡

Àü±¹ ºÐȸÀåµµ ÀÌ·± ½Ã´ëÀû ȯ°æº¯È­¿¡ ¿¹¹ÎÇÏ°Ô ¹ÝÀÀÇϰí ÀÖ´Ù´Â °á°ú°¡ ³ª¿Ô´Ù. ¾à»ç°ø·ÐÀº Àü±¹ ºÐȸÀåÀ» ´ë»óÀ¸·Î Á¶Á¦·Îº¿ÀÇ µîÀå µî AI ½Ã´ëÀÇ µµ·¡°¡ ¾à»ç»çȸ¿¡ ¾î´À Á¤µµ ¿µÇâ·ÂÀÌ ÀÖÀ» °ÍÀ¸·Î »ý°¢ÇÏ´À³Ä´Â Áú¹®À» ´øÁ³´Ù.

´äº¯Àº ¿¹»óµÇ´Â ¿µÇâ·ÂÀÇ Á¤µµ¿¡ µû¶ó 0¿¡¼­ 10±îÁö ôµµ·Î Ç¥½ÃÇϵµ·Ï Çß´Ù. 10¿¡ °¡±î¿ï¼ö·Ï ¿µÇâ·ÂÀÌ Å« °ÍÀÌ´Ù.

ÀÌ ¼³¹®¿¡ ÀÀ´äÇÑ ºÐȸÀå 161¸íÀÇ ¿¹»ó ¿µÇâ·Â Æò±ÕÄ¡´Â 6.4°¡ ³ª¿Ô´Ù. AIÀÇ ½Ã´ë°¡ ¾à»ç»çȸ¿¡ ÀûÁö ¾ÊÀº ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î Àü¸ÁÇÑ °ÍÀÌ´Ù.

ƯÈ÷ ÀÀ´äÇÑ Ã´µµ¸¦ ºÐ¼®ÇÑ °á°ú 50¼¼ ÀÌÇÏ ÀþÀº ºÐȸÀå°ú ¿©¼º ºÐȸÀå, Ưº°±¤¿ª½Ã µî ´ëµµ½Ã ºÐȸÀåÀÌ Á¶Á¦·Îº¿ µî AI½Ã´ë¿¡ ´õ ¹Î°¨ÇÑ °ÍÀ¸·Î ³ªÅ¸³µ´Ù. 

ºÐȸÀå 70% "AI½Ã´ë ¾à»ç ´Ù¸¥ ÇüÅ·ΠÀü¹®¼º ¹ßÈÖ"

4Â÷ »ê¾÷Çõ¸í °ü·Ã ¾à»çÀÇ ¹Ì·¡´Â?

4Â÷ »ê¾÷Çõ¸í°ú °ü·ÃµÈ ¾à»çÀÇ ¹Ì·¡¿¡ ´ëÇØ¼­´Â Àü±¹ ºÐȸÀåÀº AI½Ã´ë ¾à»ç Á÷´ÉÀÌ ¾î´À Á¤µµ À§ÃàµÉ ¼ö´Â ÀÖÁö¸¸ ¾ø¾îÁöÁö´Â ¾ÊÀ» Á÷¾÷À¸·Î ³»´ÙºÃ´Ù.

Àü±¹ ºÐȸÀå(161¸í) Áß 70.2%¿¡ À̸£´Â 113¸íÀº ¾à»ç´Â ÇöÀç¿Í ´Ù¸¥ ÇüÅ·ΠÀü¹®¼ºÀ» ¹ßÈÖÇÒ °ÍÀ̶ó°í ´äº¯Çß´Ù. Áö±Ýó·³ ´Ü¼øÇÑ Ã³¹æÁ¶Á¦¿¡ ¸Å¸ôµÇ±âº¸´Ù´Â º¹¾à»ó´ã µî ¾à»ç¸¸ÀÌ ÇÒ ¼ö Àִ ƯȭµÈ ¿µ¿ª¿¡¼­ ±× ¿ªÇÒÀ» ÇÏ°Ô µÉ °ÍÀ̶õ ¸»ÀÌ´Ù.

¾à»çÀÇ ¿ªÇÒÀÌ Å©°Ô À§ÃàµÉ °ÍÀ̶õ ´äº¯µµ 28.6%(46¸í)¿¡ ´ÞÇØ ÀÌ¿¡ ´ëºñÇÑ ¾à»ç»çȸÀÇ ³ë·ÂÀÌ ÇÊ¿äÇØ º¸ÀδÙ. ¾à»ç¶õ Á÷¾÷ÀÌ ¾Æ¿¹ »ç¶óÁú °ÍÀ̶õ ´äº¯Àº 0.6%(1¸í)¿¡ ºÒ°úÇß´Ù.

ºÐȸÀå 41.6% "ȯÀÚ¿ÍÀÇ Á¢ÃË¸é ´Ã·Á¾ß"

¾à»ç Á÷´ÉÀÇ ¹Ì·¡ Á¸¸³À» À§ÇØ ´ëºñÇØ¾ß ÇÒ °ÍÀº?

AIÀÇ ½Ã´ë, ¾à»çÀÇ ¹Ì·¡°¡ ºÒ¾ÈÇÏ´Ù¸é ¾î¶² °ÍÀ» ÁغñÇØ¾ß ÇÒ±î. ±× ÇØ¹ýÀº ¡®È¯ÀÚ¡¯¿¡ ÀÖ´Ù°í ºÐȸÀåµéÀº »ý°¢Çß´Ù. 

ºÐȸÀå 161¸í Áß 41.6%¿¡ ÇØ´çÇÏ´Â 67¸íÀº ¡®¾à»çÁ÷´ÉÀÇ ¹Ì·¡ Á¸¸³À» À§ÇØ ´ëºñÇØ¾ß ÇÒ °ÍÀÌ ÀÖ´Ù¸é ¹«¾ùÀÌ ÀÖ´À³Ä¡¯¶ó´Â Áú¹®¿¡ ¡®È¯ÀÚ¿ÍÀÇ ´ë¸éÁ¢Ã˸é È®´ë¡¯¶ó°í ÀÀ´äÇß´Ù.

¿©±â¿¡´Â ȯÀÚ¿ÍÀÇ ¼ÒÅë°ú ȯÀÚ¸¦ ´ëÇϴ ŵµ, ȯÀÚ¿ÍÀÇ °ü°è Çü¼º µîÀÌ Æ÷ÇԵȴÙ. AI°¡ ÇÒ ¼ö ÀÖ´Â ´Ü¼øÁ¶Á¦´Â AI°¡ ÇÏ°í ¾à»ç¸¸ÀÌ ÇÒ ¼ö Àִ ȯÀÚ¿ÍÀÇ »ó´ã¿¡ ÁýÁßÇÏ´Â °ÍÀÌ ¹Ì·¡½Ã´ë ¾à»çÀÇ »ýÁ¸¹ýÀ̶ó´Â Àǹ̴Ù.

±× ´ÙÀ½À¸·Î ºÐȸÀåÀÇ 35.4%(57¸í)´Â ÃÖ±Ù ¾à»ç»çȸ¿¡¼­ °ü½ÉÀ» ²ø°í ÀÖ´Â ¡®Àü¹®¾à»ç µî Àü¹®¼º °­È­¡¯¸¦ ²Å¾Ò´Ù. ´ëÇѾà»çȸ¿¡¼­µµ ³íÀǸ¦ ÁøÇàÇϰí ÀÖ°í ¼­¿ïÁöºÎ¿¡¼­µµ ±³À°°­Á¸¦ °³¼³ÇÏ´Â µî ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖ´Â »óȲÀÌ´Ù.

¾à·á¼­ºñ½ºÀÇ ÁúÀ» Çâ»óÇÏÀÚ´Â ÀÀ´äÀº 14.3%(23¸í), Á¤Ä¡‧»çȸÀû ¿ª·®À» °­È­ÇØ¾ß ÇÑ´Ù´Â ´äº¯Àº 6.8%(11¸í), AI ½Ã´ë¸¦ ¸Â¾Æ ¾àÇдëÇÐÀÇ ¼º°ú±â¹Ý±³À°(Outcome-based Education)À¸·ÎÀÇ ÀüȯÀº 1.9%(3¸í)ÀÇ ºÐÆ÷¸¦ ³ªÅ¸³Â´Ù.

¾à»ç°ø·ÐÀÇ Ã¢°£¼³¹®Á¶»ç °á°ú´Â 7¿ù10ÀÏÀÚ Áö¸é½Å¹® A5¸éºÎÅÍ B24¸éÀ» Âü°íÇϽñ⠹ٶø´Ï´Ù.

 

 

Ãâó : http://www.kpanews.co.kr/article/show.asp?idx=185357&table=article&category=H&search=&keyword=&page=1&go_back=1 

 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
123 [±â»ç]ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò °á»ê ÀÚü°¨»ç ¼ö°¨ °ü¸®ÀÚ 2018-02-19 1330
122 [±â»ç]¾à±¹, '°í°´»ó´ã ±â¹ý ¡¤ ÀÏ¹Ý¾à ±³À°' °æ¿µ°³¼± À§ÇØ °¡Àå ÇÊ¿ä °ü¸®ÀÚ 2018-02-19 1564
121 [±â»ç]ÀÏ»ó¿¡ ÁöÄ£ ¾à»çµé, ³ª¸¸ÀÇ Ãë¹Ì¿¡ ºüÁ®º¸¶ó °ü¸®ÀÚ 2018-02-05 1333
120 [±â»ç]°è¼ÓµÇ´Â °ø°ø½É¾ß¾à±¹ °³¼³¡¦À̹ø¿£ ¾È¾ç¡¤È­¼º °ü¸®ÀÚ 2018-02-02 1773
119 [±â»ç]Á¶Á¦ °³³ä, Àü¹®¼º¿¡ ¸Â°Ô ¹Ù²ã¾ß °ü¸®ÀÚ 2018-01-31 1491
118 [±â»ç]ȸ¿øÀÌ Áñ±â´Â ¸ð¹ÙÀÏ È¨ÆäÀÌÁö ±¸Ãà °ü¸®ÀÚ 2018-01-30 1427
117 ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ±è´ë¿ø ¼ÒÀå ½Å³â»ç ±è´ë¿ø 2018-01-05 1591
116 [±â»ç][Ä®·³] ÀǾàǰ ¾ÈÀü»ç¿ë±³À°ÀÇ ¼º°ú¿Í °úÁ¦ °ü¸®ÀÚ 2017-12-27 1578
115 [±â»ç]¾î¸°ÀÌ ´Ùºóµµ Áúȯ¡¤ÀǾàǰ Á¤º¸, Á÷Á¢ È®ÀÎÇØº¸¼¼¿ä °ü¸®ÀÚ 2017-11-27 1713
114 [±â»ç][±â°í] »ìÃæÁ¦°è¶õ, À¯Çع°Áú »ý¸®´ëÀÇ ¼ÒºñÀÚ ½Ã°¢ °ü¸®ÀÚ 2017-09-15 1890
113 [±â»ç]"°æ±â ½É¾ß°ø°ø¾à±¹ ÀûÇÕ"...°³Àξ౹¡¤24½Ã°£ ¼­ºñ½ºÇü Á¢±Ù °ü¸®ÀÚ 2017-09-07 2114
112 [±â»ç]½É¾ß¾à±¹ µµÀÔ...¾à°è "Ãë¾à½Ã°£´ë º¸¿Ï" vs Á¤ºÎ "ÀçÁ¤ ºÎ´ã" °ü¸®ÀÚ 2017-09-07 2068
111 [±â»ç]¼­¸é¹æ½Ä Çã¿ë, ¾à»ç Àνĺ¯È­¿¡ ±àÁ¤Àû ¿µÇâ °ü¸®ÀÚ 2017-08-29 2255
110 [±â»ç]ÀǾàǰÁ¤Ã¥ ¿¬±¸¼Ò, »ó¹Ý±â ÀÚü°¨»ç ¼ö°¨ °ü¸®ÀÚ 2017-08-16 1517
109 [±â»ç]¾à»ç Á÷´É ¹Ì·¡ Á¸¸³ÀÇ ÇØ¹ýÀº 'ȯÀÚ¿ÍÀÇ ¼ÒÅë' °ü¸®ÀÚ 2017-07-12 1884

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  [10]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»